Hong Kong's equity capital markets raised nearly $44 billion in the first half of 2026, a five-year high driven almost entirely by Chinese AI and semiconductor companies that can't, or won't, list in New York.
Ernst & Young counts 84 new listings in Hong Kong during H1 2026, raising HK$209.8 billion, up 92% year-on-year in funds raised. First-day returns averaged more than 60%. Those aren't the numbers of a market warming up. That's a structural redirect of capital, and it's happening fast enough that the bankers facilitating it are already talking about Hong Kong surpassing its 2021 peak by year-end, with PwC projecting full-year fundraising of HK$320 billion to HK$350 billion.
The composition of what's listing tells you everything. Technology and industrial companies accounted for 53 of the 84 new listings, with large language model developers and semiconductor firms leading the charge. Zhipu, founded by researchers from Tsinghua University, became the first major Chinese LLM company to go public anywhere, listing in Hong Kong in January and valuing the business at roughly HK$4.3 billion. MiniMax followed a day later and doubled on its first trading day. Both stocks have since surged more than 400% from their IPO prices, according to data highlighted by Bloomberg. You don't see moves like that without retail money piling in behind institutional anchors, and retail money follows a narrative. Right now the narrative is that China's AI sector, written off after years of regulatory crackdowns and US chip restrictions, has turned the corner.
The sentiment shift starts with DeepSeek. When the Hangzhou-based lab released its R1 model in early 2025 and demonstrated competitive performance at a fraction of the compute cost that US labs were spending, it forced a reassessment of whether Chinese AI companies needed unrestricted access to Nvidia's highest-end chips to build competitive products. That reassessment is now showing up in order books. International investors who had written China tech off as uninvestable after the 2021 regulatory crackdown are rotating back in, and Hong Kong is where they can do it most cleanly.
CATL, the world's largest EV battery maker, helped set the template when it raised $4.5 billion in Hong Kong in June 2025. Its H-shares now trade at an 11% premium to the mainland-listed A-shares, according to South China Morning Post. That gap matters: it tells you Hong Kong investors are willing to pay more than mainland investors for the same underlying business, partly because Hong Kong offers easier access for international capital. The companies rushing to list in 2026 read that signal correctly.
Meanwhile, the door to New York has narrowed considerably. Nasdaq tightened listing standards for Chinese companies in Q2 2026, and the Holding Foreign Companies Accountable Act continues to hang over any Chinese firm already trading in the US. As Reuters reported, only one Chinese company received CSRC approval for a US listing during the entire quarter. The arithmetic is simple: if New York is increasingly inaccessible and Hong Kong is delivering 60%-plus first-day pops, you list in Hong Kong.
The part worth watching carefully
Don't mistake a momentum trade for a permanent repricing. The same conditions that are attracting capital to Hong Kong's AI listings can reverse quickly, and there are already early signs of strain at the edges. Some companies that listed in recent months have seen their shares stall once early enthusiasm faded. Investors in VC and crossover funds with exposure to Chinese AI names should note that 60% average first-day returns, while extraordinary, are also a warning sign. That kind of pop reflects demand from investors who couldn't get allocations in the IPO, not necessarily a considered view of long-term value.
The structural argument is more durable than the momentum argument. A+H dual listings, where a company trades on both the Shanghai or Shenzhen exchange and in Hong Kong, accounted for 60% of all IPO funds raised in Q1 2026, according to KPMG's quarterly review. That structure gives mainland companies access to international capital while keeping a domestic investor base, and it's increasingly the default playbook for Chinese firms with ambitions beyond their home market. More than 400 companies are currently in the Hong Kong listing queue, which tells you the pipeline isn't going away even if sentiment wobbles.
Frankly, the harder question isn't whether Hong Kong sustains its IPO volume. It probably does, given the regulatory backdrop in the US and the structural reforms the HKEX has pushed through to attract pre-revenue tech companies. The harder question is whether Western institutional investors, who remain notably cautious on Hong Kong assets for reasons that go beyond valuation, gradually increase their allocations or stay on the sidelines. If they stay out, the market's depth depends heavily on mainland retail flows and regional sovereign wealth, which are less patient capital. That's a different risk profile than investors used to when they evaluated a New York IPO.
What's already clear is that H1 2026 has produced something more than a bounce. It's produced a functioning alternative to New York for Chinese tech companies that need public capital, and it's done so at a moment when the US door is closing. Whether Hong Kong can hold that position through a cycle, rather than just a bull run, is the question that will define the next two years.
Also read: AI's power hunger is turning energy infrastructure into the hottest new IPO category • Steve Eisman says investors betting on hyperscalers in the AI race are funding the wrong side of the trade • Solana now processes 95% of the world's tokenized stock trades but its token price tells a different story
